British drugmaker GlaxoSmithKline Plc (GSK.L) has picked Dave Lewis, former chief executive of Tesco Plc (TSCO.L), to chair its consumer healthcare unit, which is due to be spun off next year, a source familiar with the matter said on Sunday.
Confirmation of Lewis’s appointment as non-executive chairman of the arm that owns brands including Sensodyne toothpaste could come as soon as Monday, the source said.
Lewis left Tesco in September after six years as CEO.
GSK owns 68% of the unit and Pfizer Inc (PFE.N) the remainder. In July, GSK said its current head, Brian McNamara, would take over as CEO once it was spun off.
GSK said in October it was on track to spin the unit off next year at a valuation of upwards of 40 billion pounds ($53 billion).